ZKZsolt Káposztás

Zsolt Káposztás

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zsolt Káposztás has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Clinical and economic impact of a multidisciplinary antimicrobial stewardship program in a septic surgery unit

    by Adrienn Biró, Lilla Sáfár, Sára Merczel, Zsolt Káposztás

    Objective: This study evaluated the clinical, epidemiological, and economic outcomes associated with the implementation of a multidisciplinary antimicrobial stewardship program (ASP) at the 24-bed Septic Surgery Unit of the Somogy County Kaposi Mór Teaching Hospital. The primary objective was to assess changes in direct antimicrobial procurement expenditures, consumption metrics, and healthcare-associated pathogen patterns, while monitoring 30-day all-cause mortality as a core safety endpoint. Methods: In this quantitative retrospective before-after cohort study following the ORION and SQUIRE 2.0 guidelines, data from two one-year periods were evaluated: pre-intervention (1 October 2022 to 30 September 2023) and post-intervention (1 October 2023 to 30 September 2024). Evaluated metrics included Defined Daily Dose (DDD) per 1,000 patient-days, Days of Therapy (DOT) per 1,000 patient-days, mean overall duration of antibiotic (AB) therapy per treated patient, gross institutional procurement costs, length of stay (LOS), and 30-day all-cause mortality from admission. Group comparisons were analyzed using the Independent Samples t-test for continuous variables, and the Chi-square (χ²) test or Fisher’s exact test for categorical variables. Results: Following ASP implementation, cumulative DDD increased by 23.00% (from 4,037.44 to 4,965.85 DDD, p = 0.003, 673.52 to 832.36 DDD/1,000 patient-days), while the total drug procurement cost decreased by 25.09% (from 6,451,451 HUF to 4,832,680 HUF, p = 0.006). Active AB exposure altered from 626.88 to 691.26 DOT per 1,000 patient-days. The mean duration of therapy per treated patient decreased from 5.68 (SD +/- 3.22) to 5.30 (SD +/- 3.23) days ( p = 0.028), and de-escalation practices improved, with reduced intravenous (IV) (80.00% to 71.15%) and increased oral treatment (PO) (20.00% to 28.85%, p < 0.001). The incidence density (ID) of glycopeptide-resistant Gram-positive cocci decreased by 87.07% ( p = 0.039), and methicillin-resistant staphylococci decreased by 74.13% ( p = 0.034), observed in conjunction with reinforced barrier infection control measures. All-cause 30-day mortality was 10.03% pre-intervention and 9.00% post-intervention ( p = 0.545), confirming non-inferior clinical safety. Conclusions: Implementation of a multidisciplinary ASP in a septic surgery environment was associated with substantial direct cost savings, accelerated IV-to-PO conversion, and a reduced mean duration of patient therapy without compromising clinical safety, despite an administrative expansion in cumulative DDD metrics.

  • Open Access

    Two Decades of Living with Echinococcus multilocularis: A Clinical Epidemiology Study on Human Alveolar Echinococcosis in Hungary

    by Eszter Csulak, Damján Pekli, Ágnes Csivincsik, Sibusiso Moloi, Balázs Dezsényi, József Danka, Krisztina Hagymási, Oszkár Hahn, Judit Halász, Norbert Völcsei, et al.

    Introduction The zoonotic parasite Echinococcus multilocularis emerged in Hungary in the early 2000s. During the next two decades, it continuously spread in both wildlife and the human population. The first comprehensive epidemiological study on human alveolar echinococcosis (HAE) was carried out in 2018. Then, a remarkable increase in HAE cases was detected in Hungary. Methods Our study aimed to identify the potential causes of trend alterations in the epidemiology of HAE. Thus, we compared the terms before (2003–2018) and after (2019–2024) the comprehensive analysis, focusing on disease outcomes and their associated background factors. Results We found that, during the latter study period, the prognosis of HAE improved (proportion of improving cases increased from 23.5% to 60.9%, p = 0.0006) owing to the shortening of diagnostic delay (47.1% versus 78.3% of delay within 12 months, p = 0.029), development in surgery (17.6% versus 26.1% of surgeries were R1/R2, p = 0.57) and medication (35.3% versus 73.9% of medications proved adequate, p = 0.015); however, the proportion of advanced-stage cases entering the healthcare system remained high (56.25% versus 56.52%). On the other hand, a non-significant increase in case numbers was experienced in the southwestern part of the country (11.77% versus 26.09% of all cases in Hungary). Conclusion We conclude that public interest arose from the first comprehensive HAE study that increased disease awareness within the healthcare system and contributed to better diagnoses and more efficient therapy. However, public awareness needs improvement, since the proportion of advanced-stage HAE did not decrease between the two study periods. Besides, the southwestern hotspot needs more attention and intervention.


  • Open Access

    Retrospective multidisciplinary analysis of human alveolar echinococcosis in Hungary using spatial epidemiology approaches

    by Eszter Csulak, Ágnes Csivincsik, Tamás Sréter, Norbert Solymosi, József Danka, Zsolt Káposztás, Gábor Nagy, Balázs Dezsényi

    Human alveolar echinococcosis (HAE), which is caused by the larval stage of the Echinococcus multilocularis tapeworm, is an increasing healthcare issue in Hungary. Among the 40 known cases in the country, 25 were detected in the last five years. Our study aimed to reveal the geographically underlying risk factors associated potentially with these cases. We investigated the spatial pattern and the impact of potential risk factors of HAE by cluster analysis, and local and global regression models. Also, a questionnaire survey on the patients’ lifestyle was implemented. We found two HAE hyperendemic foci in the country with very dissimilar biotic and climatic features, and controversial impact of different environmental factors. Four factors, viz. forest cover (β = 0.291, p < 0.0001), surface soil wetness (β = − 0.157, p = 0.033), fox infection rate (β = 0.369, p < 0.0001) and socio-economic development (β = − 0.216, p = 0.009), proved important countrywide. The most forested and the least developed districts showed the highest HAE risk. Among the patients, kitchen gardening (67.86%) and dog ownership (67.86%) seemed the riskiest activities. Our models detected an anomaly in one of the poorest regions of Hungary where all risk factors behaved contrary to that of the neighboring areas. This phenomenon was supposed to be the result of under-detection of the disease, and it called attention to the urgent priority of knowledge dissemination to the public and the healthcare professionals.


  • Open Access

    Are chemical compounds in medical mushrooms potent against colorectal cancer carcinogenesis and antimicrobial growth?

    by John M. Macharia, Lu Zhang, Ruth W. Mwangi, Nora Rozmann, Zsolt Kaposztas, Tímea Varjas, Miklós Sugár, Huda Alfatafta, Márton Pintér, Raposa L. Bence

    After cardiovascular diseases, cancer is the second main cause of death globally. Mushrooms have been demonstrated to contain amalgamation with properties capable of inhibiting carcinogenesis and microbial growth, principally secondary metabolites such as quinolones, steroids, terpenes, anthraquinones, and benzoic acid derivatives among others. This study aimed to substantiate their potency concerning colon cancer carcinogenesis and antimicrobial growth. A systematic search of important literature was performed considering all the articles published until April 2022. Screening was performed by searching the BMC Springer, Elsevier, Embase, Web of Science, Ovid, and MEDLINE databases. In addition, Google Scholar was used to supplement information. Titles and abstracts that matched the established criteria were selected for full-text article scrutiny and subsequently used in the updated present review. Bioactive compounds present in medicinal mushrooms such as ascorbic acid, organic acids, flavonoids, polysaccharides, glycosides, phenols, linoleic acid, grifolin, and tocopherols among other compounds play a key role in suppressing the proliferation of cancerous cells and selectively act as antibacterial and antifungal agents. These metabolites actively scavenge oxygen free radicals, hydroxyl radicals, and nitrite radicals that would otherwise increase the risks of the growth and development of cancerous cells. Mushrooms' bioactive compounds and metabolites actively inhibit nuclear factor-kappa activation, protein kinase B processes, and ultimately the expression of Cyclooxygenases 2 in cancerous cells. Medicinal mushrooms should be considered as alternative natural chemo-preventive agents in the global fight against colon cancer and the evolution of drug-resistant pathogenic microorganisms, as they exhibit robust potency. They have not been reported to exhibit adverse harmful effects compared to synthetic chemotherapies, yet they have been reported to demonstrate significant beneficial effects.


  • Open Access

    Significance of preoperative blood tests in the prognosis of colorectal cancer: A prospective, multicenter study from Hungary

    by Adrienn Biró, Péter Kolozsi, Attila Nagy, Zsolt Varga, Zsolt Káposztás, Dezső Tóth

    Background: The focus of this study was to analyze the prognostic value of different combinations of inflammatory and coagulation factors using preoperative blood and to appraise the clinical importance of these biomarkers in colorectal cancer patients.Methods: A prospective, multicenter study included patients undergoing radical colorectal surgery in three county hospitals. Inflammatory and coagulation markers were analyzed preoperatively.Results: Two hundred and one patients were included. We examined patients based on their tumor localization. Colon cancer group involved patients with the tumor localized in the colon (n = 105, 52.24%) and rectal cancer group the patients with the tumor in the rectum (n = 96, 47.76%). Examining coagulation factors, univariate Cox analysis of colon cancer patients showed that activated partial thromboplastin time (p = 0.020) was significantly associated with overall survival, but we could not prove it in multivariate analysis. In colon cancer patients, neutrophil‐to‐lymphocyte ratio (NLR, p < 0.001) was positively correlated with tumor size and had significant association (χ2 = 5.48, p = 0.019, df = 1) with perineural invasion. Univariate and multivariate Cox analysis of colon cancer patients showed that NLR (p = 0.011 and p = 0.048) was significantly associated with disease‐free survival (DFS).Conclusion: NLR was proved to be an independent prognostic factor for DFS in patients with non‐metastatic colon cancer. NLR might help to recognize the high‐risk patients between patients with the same tumor‐node‐metastasis stage and could help with the decision on adjuvant chemotherapy. Since the biomarkers in preoperative blood tests are habitually evaluated, NLR could be an inexpensive prognostic marker that can be easily assessed in clinical practice.


  • Open Access

    How successful is liver resection for colorectal cancer liver metastases in patients over 75 years old?

    by Nicholas George Mowbray, Carven Chin, Patricia Duncan, David O’rEilly, Zsolt Kaposztas, Sameer Junnarkar, Nagappan Kumar

    Nicholas George Mowbray, Carven Chin, Patricia Duncan, David O’Reilly, Zsolt Kaposztas, Sameer Junnarkar, and Nagappan Kumar. Ann Hepatobiliary Pancreat Surg 2021;25:18-24. https://doi.org/10.14701/ahbps.2021.25.1.18